应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
PFE 辉瑞
交易中 07-09 14:11:52 EDT
25.45
-0.17
-0.67%
最高
25.84
最低
25.34
成交量
2,336万
今开
25.64
昨收
25.63
日振幅
1.95%
总市值
1,447亿
流通市值
1,445亿
总股本
56.85亿
成交额
5.95亿
换手率
0.41%
流通股本
56.76亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
辉瑞7月8日成交额为13.13亿美元
市场透视 · 04:53
辉瑞7月8日成交额为13.13亿美元
美股医药板块股票走高Moderna涨超10%礼来、辉瑞涨超2%诺和诺德涨超1%。
智通财经 · 07-08 15:24
美股医药板块股票走高Moderna涨超10%礼来、辉瑞涨超2%诺和诺德涨超1%。
【美股异动 | 医药板块股票走高 Moderna(MRNA.US)涨超9%】智通财经APP获悉，周二，美股医药板块股票走
智通财经 · 07-08 14:56
【美股异动 | 医药板块股票走高 Moderna(MRNA.US)涨超9%】智通财经APP获悉，周二，美股医药板块股票走
辉瑞7月7日成交额为8.83亿美元
市场透视 · 07-08 04:46
辉瑞7月7日成交额为8.83亿美元
近期交易合作|阿斯利康有意购入依沃西单抗，晶泰科技与辉瑞扩大合作
药菓 · 07-07 10:01
近期交易合作|阿斯利康有意购入依沃西单抗，晶泰科技与辉瑞扩大合作
汇丰银行：将辉瑞公司目标价从26美元上调至28美元。
金融界 · 07-07 05:19
汇丰银行：将辉瑞公司目标价从26美元上调至28美元。
汇丰银行：将辉瑞公司目标价从26美元上调至28美元。
智通财经 · 07-07 05:18
汇丰银行：将辉瑞公司目标价从26美元上调至28美元。
辉瑞中国分享数据本地化合规经验
DoNews · 07-04
辉瑞中国分享数据本地化合规经验
君实生物午后涨超10% PD-(L)1/VEGF赛道景气度提高 机构称JS207具备BD潜力
智通财经 · 07-04
君实生物午后涨超10% PD-(L)1/VEGF赛道景气度提高 机构称JS207具备BD潜力
辉瑞7月2日成交额为9.29亿美元
市场透视 · 07-03
辉瑞7月2日成交额为9.29亿美元
辉瑞CD47遇挫，莫得纳mRNA流感疫苗数据积极、信诺维推进ADC
医药经济报 · 07-02
辉瑞CD47遇挫，莫得纳mRNA流感疫苗数据积极、信诺维推进ADC
招募受试者困难 辉瑞(PFE.US)终止淋巴瘤药物maplirpacept 2期临床试验
智通财经 · 07-02
招募受试者困难 辉瑞(PFE.US)终止淋巴瘤药物maplirpacept 2期临床试验
【招募受试者困难 辉瑞(PFE.US)终止淋巴瘤药物maplirpacept 2期临床试验】智通财经APP获悉，因招募受
智通财经 · 07-02
【招募受试者困难 辉瑞(PFE.US)终止淋巴瘤药物maplirpacept 2期临床试验】智通财经APP获悉，因招募受
辉瑞7月1日成交额为14.81亿美元
市场透视 · 07-02
辉瑞7月1日成交额为14.81亿美元
辉瑞6月30日成交额为10.85亿美元
市场透视 · 07-01
辉瑞6月30日成交额为10.85亿美元
23亿美元打水漂？辉瑞终止最后一项CD47明星实验
生物药大时代 · 07-01
23亿美元打水漂？辉瑞终止最后一项CD47明星实验
辉瑞公司6月30日宣布新型抗菌药物思福诺（注射用氨曲南阿维巴坦钠以下简称“氨曲南/阿维巴坦”）获得国家药品监督管理局正式
智通财经 · 06-30
辉瑞公司6月30日宣布新型抗菌药物思福诺（注射用氨曲南阿维巴坦钠以下简称“氨曲南/阿维巴坦”）获得国家药品监督管理局正式
【晶泰科技(02228.HK)与辉瑞深化战略合作，共建AI药物与新材料研发分子模拟平台】智通财经APP获悉，今天，全球领
智通财经 · 06-30
【晶泰科技(02228.HK)与辉瑞深化战略合作，共建AI药物与新材料研发分子模拟平台】智通财经APP获悉，今天，全球领
晶泰科技宣布与辉瑞扩大战略合作共同开发全新一代的分子模拟平台以驱动新药研发。此次合作旨在进一步融合先进的物理算法的精确度
智通财经 · 06-30
晶泰科技宣布与辉瑞扩大战略合作共同开发全新一代的分子模拟平台以驱动新药研发。此次合作旨在进一步融合先进的物理算法的精确度
晶泰科技与辉瑞深化战略合作，共建AI药物与新材料研发分子模拟平台
动脉网 · 06-30
晶泰科技与辉瑞深化战略合作，共建AI药物与新材料研发分子模拟平台
加载更多
公司概况
公司名称：
辉瑞
所属市场：
NYSE
上市日期：
--
主营业务：
辉瑞公司于1942年6月2日根据特拉华州法律成立。公司是一家以研究为基础的全球性生物制药公司。公司运用科学和全球资源，通过发现、开发、制造和分销保健产品（包括创新药物和疫苗），为人们带来延长和显著改善其生活的疗法。公司在发达国家和新兴市场开展工作，致力于促进健康、预防、治疗和治愈这个时代最令人恐惧的疾病。公司与医疗保健提供商、政府和当地社区合作，支持并扩大在全球范围内获得可靠、负担得起的医疗保健服务。
发行价格：
--
{"stockData":{"symbol":"PFE","market":"US","secType":"STK","nameCN":"辉瑞","latestPrice":25.4525,"timestamp":1752084711973,"preClose":25.625,"halted":0,"volume":23358604,"delay":0,"floatShares":5675901727,"shares":5685365587,"eps":1.38322,"marketStatus":"交易中","change":-0.1725,"latestTime":"07-09 14:11:52 EDT","open":25.635,"high":25.8399,"low":25.34,"amount":595239410.523848,"amplitude":0.019508,"askPrice":25.46,"askSize":8580,"bidPrice":25.45,"bidSize":3252,"shortable":3,"etf":0,"ttmEps":1.38322,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752091200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-819144000000,"exchange":"NYSE","adjPreClose":25.625,"dividendRate":0.066398,"preHourTrading":{"tag":"盘前","latestPrice":25.6,"preClose":25.625,"latestTime":"09:29 EDT","volume":90056,"amount":2311631.7042,"timestamp":1752067799561},"postHourTrading":{"tag":"盘后","latestPrice":25.59,"preClose":25.62,"latestTime":"19:59 EDT","volume":4497598,"amount":115225646.5385,"timestamp":1752019196306},"volumeRatio":0.771659,"optionData":{"bulkOrders":[{"symbol":"PFE","call":true,"expireDate":1760673600000,"strike":"26.0","timestamp":1752075706379,"price":0.86,"volume":2000,"amount":172000,"type":"*"},{"symbol":"PFE","call":false,"expireDate":1758254400000,"strike":"23.0","timestamp":1752075706379,"price":0.35,"volume":2000,"amount":70000,"type":"+"}]},"impliedVol":0.285,"impliedVolPercentile":0.308},"requestUrl":"/m/hq/s/PFE","defaultTab":"news","newsList":[{"id":"2550748504","title":"辉瑞7月8日成交额为13.13亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550748504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550748504?lang=zh_cn&edition=full","pubTime":"2025-07-09 12:53","pubTimestamp":1752036804,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，辉瑞成交额为13.13亿美元，成交额较昨日增加48.78%，当日成交量为5127.58万股。辉瑞于2025年7月8日涨1.51%，报25.62美元，该股过去5个交易日涨5.69%，年初至今涨0.04%，过去60日涨16.09%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-08|13.13亿|48.78%|5127.58万|#|2025-07-07|8.83亿|28.25%|3490.59万|#|2025-07-03|6.88亿|-25.90%|2710.46万|#|2025-07-02|9.29亿|-37.26%|3677.21万|#|2025-07-01|14.81亿|36.50%|5925.99万|辉瑞是世界上最大的制药公司之一，年销售额约为600亿美元。辉瑞在全球销售这些产品，国际销售额占总销售额的40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709125327a43f7b3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709125327a43f7b3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z3581.USD","LU0306806265.USD","LU0321505868.SGD","SG9999013999.USD","BK4599","LU1066053197.SGD","LU0456855351.SGD","SG9999011175.SGD","LU0170899867.USD","IE00BBT3K403.USD","BK4585","SG9999001176.USD","LU0234572021.USD","BK4007","LU0058720904.USD","LU0225771236.USD","BK4581","LU0306807586.USD","SG9999002224.SGD","LU1883839398.USD","LU1894683348.USD","IE00B19Z3B42.SGD","LU0122379950.USD","LU0985481810.HKD","PFE","LU0868494617.USD","LU1023059063.AUD","LU0321505439.SGD","IE00BLSP4452.SGD","BK4550","IE00BLSP4239.USD","SG9999002232.USD","LU0225284248.USD","LU1057294990.SGD","IE0002270589.USD","SG9999003800.SGD","LU1894683264.USD","LU0289739699.SGD","SG9999001176.SGD","BK4534","BK4588","SGXZ57979304.SGD","IE000M9KFDE8.USD","LU1066051498.USD","BK4568","BK4533","BK4592"],"gpt_icon":1},{"id":"2549392529","title":"美股医药板块股票走高Moderna涨超10%礼来、辉瑞涨超2%诺和诺德涨超1%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2549392529","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549392529?lang=zh_cn&edition=full","pubTime":"2025-07-08 23:24","pubTimestamp":1751988290,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"36aa7b3b0e5d12a0b0767a4494ad1a18","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0321505439.SGD","LU2237443549.SGD","LU2491050154.USD","LU1093756325.SGD","NVO","LU2063271972.USD","LU2211815571.USD","LU2236285917.USD","IE00BK4W5L77.USD","LU2750360997.AUD","LU0316494557.USD","BK4592","SG9999001176.USD","LU0256863902.USD","LU0868494617.USD","BK4532","LU0061475181.USD","LU2112291526.USD","IE0009355771.USD","LU0306806265.USD","LU2357305700.SGD","SG9999014914.USD","LU0708995401.HKD","LU2461242641.AUD","BK1515","LU0106261372.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU0170899867.USD","SG9999002224.SGD","IE0004445239.USD","LU2552382058.USD","LU1551013425.SGD","LU2023250504.SGD","SG9999015978.USD","SG9999001176.SGD","PFE","LU1868836591.USD","09939","LU2491049909.HKD","LU1093756168.USD","LU0882574055.USD","LLY","SG9999015986.USD","LU0238689110.USD","LU2237443465.HKD","159938","IE00BJLML261.HKD","LU0820561818.USD","LU1974910355.USD"],"gpt_icon":0},{"id":"2549269435","title":"【美股异动 | 医药板块股票走高 Moderna(MRNA.US)涨超9%】智通财经APP获悉，周二，美股医药板块股票走","url":"https://stock-news.laohu8.com/highlight/detail?id=2549269435","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549269435?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:56","pubTimestamp":1751986600,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03347","MRNA","LU0385154629.USD","LU1718418525.SGD","LU0342679015.USD","LU0149725797.USD","IE00B775H168.HKD","LU2361044949.HKD","SG9999015945.SGD","NVO","LLY","BK4532","LU1066051225.USD","LU1732800096.USD","159938","09939","LU0225284248.USD","LU0965509101.SGD","BK1583","BK4534","LU0006306889.USD","LU1868836757.USD","LU0029864427.USD","LU0353189763.USD","LU1506573853.SGD","LU2746668461.USD","UNH","LU1934455863.HKD","LU1894683348.USD","LU1670628061.USD","LU0211327993.USD","LU0738911758.USD","LU0154236417.USD","IE00B1XK9C88.USD","159646","LU1153585028.USD","LU0061475181.USD","IE00B19Z9P08.USD","LU0882574139.USD","LU0106261372.USD","LU2279689827.SGD","SG9999017495.SGD","LU1127390331.HKD","LU1057294990.SGD","SG9999001176.USD","PFE","IE00BK4W5L77.USD","LU1037948541.HKD","LU1804176565.USD","LU0310799852.SGD"],"gpt_icon":0},{"id":"2549591360","title":"辉瑞7月7日成交额为8.83亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549591360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549591360?lang=zh_cn&edition=full","pubTime":"2025-07-08 12:46","pubTimestamp":1751950007,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，辉瑞成交额为8.83亿美元，成交额较昨日增加28.25%，当日成交量为3490.59万股。辉瑞于2025年7月7日跌0.55%，报25.24美元，该股过去5个交易日涨4.34%，年初至今跌1.44%，过去60日涨17.77%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-07|8.83亿|28.25%|3490.59万|#|2025-07-03|6.88亿|-25.90%|2710.46万|#|2025-07-02|9.29亿|-37.26%|3677.21万|#|2025-07-01|14.81亿|36.50%|5925.99万|#|2025-06-30|10.85亿|13.19%|4473.09万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708124650a69c548e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708124650a69c548e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0868494617.USD","SGXZ57979304.SGD","LU1023059063.AUD","BK4581","BK4550","IE00BLSP4452.SGD","LU1057294990.SGD","LU1066051498.USD","LU1883839398.USD","SG9999002224.SGD","SG9999003800.SGD","BK4534","LU0321505868.SGD","LU0306806265.USD","IE0002270589.USD","LU0321505439.SGD","LU0456855351.SGD","BK4588","LU1894683348.USD","BK4592","BK4568","SG9999001176.SGD","BK4585","IE000M9KFDE8.USD","LU0122379950.USD","IE00BLSP4239.USD","LU0225284248.USD","SG9999001176.USD","BK4599","LU0225771236.USD","LU0985481810.HKD","SG9999011175.SGD","BK4533","LU0289739699.SGD","IE00BBT3K403.USD","SG9999013999.USD","LU1894683264.USD","LU1066053197.SGD","LU0306807586.USD","PFE","LU0170899867.USD","LU0234572021.USD","IE00B19Z3B42.SGD","SG9999002232.USD","IE00B19Z3581.USD","LU0058720904.USD"],"gpt_icon":1},{"id":"2549736539","title":"近期交易合作|阿斯利康有意购入依沃西单抗，晶泰科技与辉瑞扩大合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2549736539","media":"药菓","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549736539?lang=zh_cn&edition=full","pubTime":"2025-07-07 18:01","pubTimestamp":1751882490,"startTime":"0","endTime":"0","summary":"02晶泰科技与辉瑞深化战略合作6月30日，晶泰科技宣布与辉瑞扩大战略合作，共同开发全新一代的分子模拟平台以驱动新药研发。07腾盛博药与健康元签署抗菌新药许可协议7月4日，腾盛博药宣布已与健康元集团签署知识产权许可及技术转移协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707191358a43bbb23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707191358a43bbb23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999003800.SGD","LU1894683264.USD","LU2462157665.USD","LU0306806265.USD","BK4550","LU2417539215.USD","LU0889565916.HKD","BK4585","IE00BBT3K403.USD","LU0985481810.HKD","BK4533","IE00BLSP4239.USD","SG9999011175.SGD","BK4592","LU1066053197.SGD","PFE","SG9999001176.USD","LU0289739699.SGD","LU0225284248.USD","LU1829250122.USD","LU1057294990.SGD","BK4568","BK4599","LU0122379950.USD","SG9999013999.USD","BK4007","SG9999002232.USD","IE0002270589.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","LU0109394709.USD","LU0321505868.SGD","IE000M9KFDE8.USD","LU0225771236.USD","LU2236285917.USD","LU0868494617.USD","LU0306807586.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU1023059063.AUD","BK4534","LU0234572021.USD","LU0170899867.USD","LU0456855351.SGD","LU0058720904.USD","BK4581","SGXZ57979304.SGD","LU0320765992.SGD","LU1894683348.USD","AZN"],"gpt_icon":1},{"id":"2549630288","title":"汇丰银行：将辉瑞公司目标价从26美元上调至28美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2549630288","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549630288?lang=zh_cn&edition=full","pubTime":"2025-07-07 13:19","pubTimestamp":1751865554,"startTime":"0","endTime":"0","summary":"汇丰银行：将辉瑞公司目标价从26美元上调至28美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/07131951525074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PFE","00005","HSBC"],"gpt_icon":0},{"id":"2549330425","title":"汇丰银行：将辉瑞公司目标价从26美元上调至28美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2549330425","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549330425?lang=zh_cn&edition=full","pubTime":"2025-07-07 13:18","pubTimestamp":1751865508,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0052756011.USD","03143","BK4533","HSBA.UK","IE0002270589.USD","LU0868494617.USD","LU0516422952.EUR","LU1057294990.SGD","SG9999001176.USD","LU1023059063.AUD","LU1481107354.HKD","LU0234572021.USD","00005","LU0122379950.USD","LU0516423174.USD","BK1601","LU1066051498.USD","LU0417516738.SGD","LU1267930227.SGD","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0321505868.SGD","LU0540923850.HKD","LU0149721374.USD","LU0225771236.USD","LU0516422366.SGD","LU0164880469.USD","BK1610","BK4568","LU0516422440.USD","LU0310800965.SGD","LU0306806265.USD","LU0321505439.SGD","HSBC","BK4521","BK4599","BK1572","LU0348735423.USD","HSHD.SI","LU0634319403.HKD","PFE","IE00B19Z3B42.SGD","LU1894683264.USD","BK4588","LU0306807586.USD","LU1894683348.USD","SG9999003800.SGD","BK4207","BK4550","LU0128525689.USD"],"gpt_icon":0},{"id":"2548350696","title":"辉瑞中国分享数据本地化合规经验","url":"https://stock-news.laohu8.com/highlight/detail?id=2548350696","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548350696?lang=zh_cn&edition=full","pubTime":"2025-07-04 15:08","pubTimestamp":1751612882,"startTime":"0","endTime":"0","summary":"7月4日上海报道，随着各国数据法规日益严格，跨国企业在华数据本地化成为关键议题。辉瑞中国数字化交付负责人陈勇在2025亚马逊云科技中国峰会上分享了企业构建本地化数据基础设施的实践经验。他表示，面对《个人信息保护法》等监管要求，建立安全、可扩展的数据基座已成为跨国企业在华发展的基础。辉瑞中国依托亚马逊云科技打造了涵盖数据分析、AI应用与业务决策支持的数字化生态，实现降本增效，并推动全球17个研发场景年度成本节省达7.5亿至10亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507041509199799948f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507041509199799948f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","LU1023059063.AUD","IE0002270589.USD","SG9999002224.SGD","SG9999013999.USD","BK4534","BK4588","IE00BLSP4452.SGD","BK4592","LU0122379950.USD","LU0058720904.USD","LU0456855351.SGD","SG9999002232.USD","BK4007","SG9999001176.USD","LU0289739699.SGD","BK4581","SG9999011175.SGD","LU0321505439.SGD","LU0170899867.USD","LU1894683348.USD","SG9999003800.SGD","LU1066051498.USD","LU0985481810.HKD","SG9999001176.SGD","LU1883839398.USD","IE00BLSP4239.USD","BK4550","LU0234572021.USD","LU1066053197.SGD","IE00B19Z3581.USD","IE000M9KFDE8.USD","BK4585","BK4599","IE00B19Z3B42.SGD","SGXZ57979304.SGD","IE00BBT3K403.USD","LU1057294990.SGD","LU1894683264.USD","BK4568","PFE","LU0225284248.USD","LU0225771236.USD","LU0868494617.USD","LU0306806265.USD","LU0321505868.SGD","LU0306807586.USD"],"gpt_icon":0},{"id":"2548354306","title":"君实生物午后涨超10% PD-(L)1/VEGF赛道景气度提高 机构称JS207具备BD潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2548354306","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548354306?lang=zh_cn&edition=full","pubTime":"2025-07-04 14:08","pubTimestamp":1751609284,"startTime":"0","endTime":"0","summary":"君实生物午后涨超10% ，截至发稿，涨9.17%，报26.2港元，成交额4.52亿港元。方正证券指出，JS207临床前数据发表，展现二代PD1抗肿瘤潜力。该行认为，JS207具备BD潜力。而仍有MNC未布局二代PD1产品，JS207具有BD潜力。截至2025年5月，MNC中仅辉瑞和默沙东通过引进布局此赛道，后续随着数据的不断成熟及联合应用潜力的不断验证，中国其他早期PD-1/VEGF双抗也将有机会BD出海。目前PD-1/VEGF双抗赛道景气度不断提高，相关标的有望持续受益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704141501a4cecd56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704141501a4cecd56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0106261372.USD","L","LU1069347547.HKD","BK4588","LU1037948897.HKD","LU1934455277.USD","LU2361044865.SGD","BK4585","LU1093756325.SGD","PD","LU1941712348.USD","SG9999002224.SGD","LU2023250504.SGD","LU0965509101.SGD","LU0203345920.USD","LU0070302665.USD","LU0058720904.USD","LU0861579265.USD","LU0965509010.AUD","IE00B1BXHZ80.USD","MRK","IE000M9KFDE8.USD","LU0122379950.USD","LU1066053197.SGD","LU0006306889.USD","688180","IE00BN8TJ469.HKD","LU0211331839.USD","IE0009355771.USD","LU1162221912.USD","LU1169590202.USD","PFE","LU0053666078.USD","LU2089984988.USD","SG9999014559.SGD","LU1917777945.USD","IE00BLSP4452.SGD","LU0203347892.USD","SG9999001176.SGD","01877","LU1061106388.HKD","LU1585245621.USD","LU1989771016.USD","LU2023250843.SGD","LU1066051225.USD","LU2361044949.HKD","LU0320765489.SGD","LU1066051498.USD","SG9999013999.USD","LU0098860793.USD","SG9999015358.SGD","LU1057294990.SGD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2548821897","title":"辉瑞7月2日成交额为9.29亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548821897","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548821897?lang=zh_cn&edition=full","pubTime":"2025-07-03 12:57","pubTimestamp":1751518672,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，辉瑞成交额为9.29亿美元，成交额较昨日减少37.26%，当日成交量为3677.21万股。辉瑞于2025年7月2日涨1.12%，报25.32美元，该股过去5个交易日涨4.37%，年初至今跌1.13%，过去60日涨12.33%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-02|9.29亿|-37.26%|3677.21万|#|2025-07-01|14.81亿|36.50%|5925.99万|#|2025-06-30|10.85亿|13.19%|4473.09万|#|2025-06-27|9.58亿|23.98%|3952.88万|#|2025-06-26|7.73亿|24.58%|3183.53万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703125801a4cc86df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703125801a4cc86df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0306806265.USD","LU0289739699.SGD","PFE","SG9999001176.USD","IE00BBT3K403.USD","LU0234572021.USD","SG9999003800.SGD","LU0170899867.USD","LU1894683264.USD","LU1057294990.SGD","BK4007","IE000M9KFDE8.USD","SG9999002232.USD","BK4588","LU0225284248.USD","IE00BLSP4239.USD","BK4568","BK4581","BK4533","LU1894683348.USD","LU0321505868.SGD","BK4592","IE00B19Z3581.USD","LU0225771236.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","LU0321505439.SGD","SGXZ57979304.SGD","BK4534","LU0985481810.HKD","BK4585","LU0122379950.USD","BK4599","LU0456855351.SGD","LU0306807586.USD","SG9999013999.USD","SG9999011175.SGD","IE0002270589.USD","SG9999002224.SGD","LU1066051498.USD","IE00BLSP4452.SGD","LU1023059063.AUD","BK4550","LU0868494617.USD","LU1883839398.USD","LU0058720904.USD","LU1066053197.SGD"],"gpt_icon":1},{"id":"2548489643","title":"辉瑞CD47遇挫，莫得纳mRNA流感疫苗数据积极、信诺维推进ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2548489643","media":"医药经济报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548489643?lang=zh_cn&edition=full","pubTime":"2025-07-02 18:07","pubTimestamp":1751450851,"startTime":"0","endTime":"0","summary":"此外，mRNA-1010的安全性和耐受性与此前Ⅲ期研究报告结果一致。该试验共在11个国家招募了40805名50岁及以上的成年患者，受试者被随机分配接受一次性接种mRNA-1010或一款已获批的标准剂量流感疫苗，随访中位时间为6个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702190402a4cb1189&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702190402a4cb1189&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001176.USD","IE00BLSP4239.USD","SG9999002224.SGD","LU1057294990.SGD","LU0321505439.SGD","LU0122379950.USD","LU0234572021.USD","IE00BLSP4452.SGD","BK4568","BK4588","SGXZ57979304.SGD","LU0868494617.USD","IE00B19Z3581.USD","IE000M9KFDE8.USD","BK4533","LU0306807586.USD","IE00B19Z3B42.SGD","LU1894683264.USD","BK4581","LU0306806265.USD","SG9999001176.SGD","SG9999002232.USD","LU0170899867.USD","LU0321505868.SGD","LU1066053197.SGD","LU0456855351.SGD","LU0225771236.USD","LU0289739699.SGD","BK4080","ADC","LU0985481810.HKD","BK4585","BK4550","LU0225284248.USD","BK4599","BK4534","BK4231","SG9999013999.USD","IE0002270589.USD","LU1883839398.USD","LU1894683348.USD","PFE","LU0058720904.USD","SG9999011175.SGD","BK4007","BK4592","LU1066051498.USD","SG9999003800.SGD","IE00BBT3K403.USD","LU1023059063.AUD"],"gpt_icon":1},{"id":"2548857780","title":"招募受试者困难 辉瑞(PFE.US)终止淋巴瘤药物maplirpacept 2期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2548857780","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548857780?lang=zh_cn&edition=full","pubTime":"2025-07-02 14:35","pubTimestamp":1751438106,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，因招募受试者困难，辉瑞公司已终止了靶向CD47的候选药物maplirpacept的二期临床试验。该药物是这家制药巨头于2021年8月以22.6亿美元收购Trillium Therapeutics时获得的核心资产。根据ClinicalTrials.gov网站上该试验页面的更新信息：\"试验终止是由于无法招募到计划数量的受试者。\"页面显示，试验取消时仅招募到6名参与者。这项二期试验原本旨在评估maplirpacept联合Monjuvi和Revlimid治疗弥漫性大B细胞淋巴瘤的效果。目前，maplirpacept针对多发性骨髓瘤的一期临床试验仍在进行中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1312948.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0321505439.SGD","LU0234572021.USD","LU0868494617.USD","BK4585","IE00BLSP4239.USD","LU0170899867.USD","LU0456855351.SGD","SG9999013999.USD","LU1894683348.USD","LU1883839398.USD","BK1576","LU1057294990.SGD","LU0985481810.HKD","SG9999011175.SGD","BK4534","LU0122379950.USD","LU0306807586.USD","BK1141","IE00BLSP4452.SGD","SG9999001176.SGD","SG9999002232.USD","BK4007","LU1894683264.USD","LU0225771236.USD","IE000M9KFDE8.USD","BK4592","LU0321505868.SGD","SG9999001176.USD","LU1066051498.USD","BK4588","BK4533","LU0289739699.SGD","BK4599","LU1023059063.AUD","BK4550","LU0058720904.USD","PFE","LU0306806265.USD","SG9999002224.SGD","SG9999003800.SGD","IE00BBT3K403.USD","BK1583","BK4581","03347","BK4568","IE00B19Z3581.USD","LU0225284248.USD","LU1066053197.SGD","SGXZ57979304.SGD","IE0002270589.USD"],"gpt_icon":0},{"id":"2548850876","title":"【招募受试者困难 辉瑞(PFE.US)终止淋巴瘤药物maplirpacept 2期临床试验】智通财经APP获悉，因招募受","url":"https://stock-news.laohu8.com/highlight/detail?id=2548850876","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548850876?lang=zh_cn&edition=full","pubTime":"2025-07-02 14:35","pubTimestamp":1751438106,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4533","LU0058720904.USD","BK4539","03347","BK4581","IE00B19Z3581.USD","BK1141","BK4592","SG9999003800.SGD","LU0306806265.USD","BK4599","LU0225771236.USD","LU1023059063.AUD","BK1576","LU0234572021.USD","LU0321505439.SGD","LU1066053197.SGD","LU0456855351.SGD","BK4007","LU0321505868.SGD","LU0225284248.USD","BK4550","BK1583","BK4139","BK4534","IE00B19Z3B42.SGD","BK1191","BK4568","IE00BBT3K403.USD","LU0306807586.USD","SG9999011175.SGD","LU0122379950.USD","IE000M9KFDE8.USD","SG9999013999.USD","SGXZ57979304.SGD","LU1894683348.USD","01477","SG9999002224.SGD","BK4585","LU1057294990.SGD","BK4588","SG9999001176.USD","IE00BLSP4239.USD","LU0868494617.USD","PFE","LU1066051498.USD","IE0002270589.USD","SG9999002232.USD","LU1883839398.USD"],"gpt_icon":0},{"id":"2548485947","title":"辉瑞7月1日成交额为14.81亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548485947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548485947?lang=zh_cn&edition=full","pubTime":"2025-07-02 12:45","pubTimestamp":1751431516,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，辉瑞成交额为14.81亿美元，成交额较昨日增加36.50%，当日成交量为5925.99万股。辉瑞于2025年7月1日涨3.3%，报25.04美元，该股过去5个交易日涨3.0%，年初至今跌2.22%，过去60日涨5.05%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-01|14.81亿|36.50%|5925.99万|#|2025-06-30|10.85亿|13.19%|4473.09万|#|2025-06-27|9.58亿|23.98%|3952.88万|#|2025-06-26|7.73亿|24.58%|3183.53万|#|2025-06-25|6.21亿|-25.69%|2560.33万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702124519a729c336&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702124519a729c336&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4452.SGD","IE00B19Z3581.USD","LU1883839398.USD","LU0058720904.USD","BK4550","LU0456855351.SGD","BK4599","LU0225284248.USD","LU0306807586.USD","LU0321505868.SGD","BK4007","LU0868494617.USD","LU1066051498.USD","BK4585","LU1066053197.SGD","LU1894683264.USD","BK4581","BK4588","LU0985481810.HKD","LU0321505439.SGD","SG9999002224.SGD","LU0234572021.USD","SG9999011175.SGD","IE00BLSP4239.USD","LU1023059063.AUD","IE0002270589.USD","BK4533","BK4592","SG9999003800.SGD","BK4534","IE00BBT3K403.USD","LU0225771236.USD","SG9999013999.USD","SGXZ57979304.SGD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0122379950.USD","LU1894683348.USD","SG9999002232.USD","LU0306806265.USD","SG9999001176.USD","LU0289739699.SGD","PFE","LU0170899867.USD","SG9999001176.SGD","LU1057294990.SGD","BK4568"],"gpt_icon":1},{"id":"2548336029","title":"辉瑞6月30日成交额为10.85亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548336029","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548336029?lang=zh_cn&edition=full","pubTime":"2025-07-01 12:29","pubTimestamp":1751344147,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，辉瑞成交额为10.85亿美元，成交额较昨日增加13.19%，当日成交量为4473.09万股。辉瑞于2025年6月30日涨0.21%，报24.24美元，该股过去5个交易日涨0.87%，年初至今跌5.35%，过去60日涨0.01%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-30|10.85亿|13.19%|4473.09万|#|2025-06-27|9.58亿|23.98%|3952.88万|#|2025-06-26|7.73亿|24.58%|3183.53万|#|2025-06-25|6.21亿|-25.69%|2560.33万|#|2025-06-24|8.35亿|9.14%|3440.42万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701122913a4c813a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701122913a4c813a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z3B42.SGD","LU0122379950.USD","SG9999011175.SGD","LU0058720904.USD","BK4585","BK4592","BK4534","LU1894683348.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU1883839398.USD","BK4007","LU0321505439.SGD","SG9999001176.SGD","SG9999002232.USD","LU1066051498.USD","LU0225771236.USD","BK4550","BK4581","BK4533","LU1066053197.SGD","IE00B19Z3581.USD","LU0985481810.HKD","LU1057294990.SGD","BK4599","BK4588","LU0234572021.USD","IE000M9KFDE8.USD","LU0456855351.SGD","PFE","SG9999013999.USD","SG9999003800.SGD","LU0321505868.SGD","LU1023059063.AUD","LU0868494617.USD","SG9999002224.SGD","BK4568","LU1894683264.USD","LU0289739699.SGD","LU0306806265.USD","LU0170899867.USD","LU0225284248.USD","SG9999001176.USD","LU0306807586.USD","IE0002270589.USD","SGXZ57979304.SGD","IE00BBT3K403.USD"],"gpt_icon":0},{"id":"2548202840","title":"23亿美元打水漂？辉瑞终止最后一项CD47明星实验","url":"https://stock-news.laohu8.com/highlight/detail?id=2548202840","media":"生物药大时代","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548202840?lang=zh_cn&edition=full","pubTime":"2025-07-01 10:32","pubTimestamp":1751337151,"startTime":"0","endTime":"0","summary":"6月30日，据外媒报道，辉瑞已经终止CD47 项目中maplirpacept 与化疗药物来那度胺联合用于复发或难治性弥漫性大B细胞淋巴瘤患者的2期研究。发言人表示，终止该研究是由于“招募受阻，并非安全或疗效翻车”。TTI-622是2021年辉瑞斥资22.6亿美元收购Trillium公司而获得的第2个CD47项目，另一个是TTI-621，此前辉瑞已经停止TTI-621的开发，这意味着辉瑞收购而来的两条CD47路线全部按下暂停键。TTI-621 和 TTI-622 结构CD47 曾经是新癌症药物的有前途的靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701103523a4c7db5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701103523a4c7db5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z3581.USD","BK4592","LU0306806265.USD","BK4550","BK4007","BK4588","IE00BLSP4452.SGD","LU1023059063.AUD","LU0289739699.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","PFE","SG9999003800.SGD","LU0321505868.SGD","SGXZ57979304.SGD","BK4534","IE0002270589.USD","BK4581","BK4599","SG9999001176.USD","BK4533","LU0170899867.USD","LU0306807586.USD","LU1057294990.SGD","BK4568","LU0122379950.USD","LU1894683264.USD","LU0234572021.USD","SG9999011175.SGD","IE00BLSP4239.USD","LU1066051498.USD","BK4585","LU0985481810.HKD","LU0321505439.SGD","LU1894683348.USD","SG9999002232.USD","SG9999013999.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","SG9999002224.SGD","IE00BBT3K403.USD","LU0058720904.USD","LU0225771236.USD","LU0868494617.USD","LU0456855351.SGD","LU0225284248.USD","LU1883839398.USD"],"gpt_icon":0},{"id":"2547030149","title":"辉瑞公司6月30日宣布新型抗菌药物思福诺（注射用氨曲南阿维巴坦钠以下简称“氨曲南/阿维巴坦”）获得国家药品监督管理局正式","url":"https://stock-news.laohu8.com/highlight/detail?id=2547030149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547030149?lang=zh_cn&edition=full","pubTime":"2025-06-30 11:18","pubTimestamp":1751253508,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SG9999001176.SGD","LU0321505868.SGD","IE0002270589.USD","LU0225284248.USD","LU0225771236.USD","IE00B19Z3581.USD","SG9999003800.SGD","IE00BLSP4239.USD","BK4007","BK4533","PFE","LU1894683264.USD","LU0170899867.USD","LU0234572021.USD","LU0321505439.SGD","LU1066051498.USD","LU0058720904.USD","SGXZ57979304.SGD","BK4599","IE000M9KFDE8.USD","SG9999002232.USD","LU0306806265.USD","SG9999013999.USD","BK4534","BK4550","LU0985481810.HKD","IE00B19Z3B42.SGD","BK4581","LU1894683348.USD","LU1057294990.SGD","LU0306807586.USD","SG9999001176.USD","IE00BBT3K403.USD","LU0456855351.SGD","LU0289739699.SGD","IE00BLSP4452.SGD","HAP","LU0122379950.USD","BK4585","LU1066053197.SGD","LU1883839398.USD","SG9999002224.SGD","BK4568","LU1023059063.AUD","LU0868494617.USD","BK4592","BK4588","SG9999011175.SGD"],"gpt_icon":0},{"id":"2547324790","title":"【晶泰科技(02228.HK)与辉瑞深化战略合作，共建AI药物与新材料研发分子模拟平台】智通财经APP获悉，今天，全球领","url":"https://stock-news.laohu8.com/highlight/detail?id=2547324790","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547324790?lang=zh_cn&edition=full","pubTime":"2025-06-30 10:21","pubTimestamp":1751250105,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1023059063.AUD","LU0456855351.SGD","SG9999002232.USD","SG9999013999.USD","159703","BK4585","LU0306807586.USD","LU1894683264.USD","LU1066051498.USD","IE000M9KFDE8.USD","BK4588","LU0321505868.SGD","BK4581","BK4592","LU0234572021.USD","LU1057294990.SGD","LU1894683348.USD","PFE","IE00BLSP4452.SGD","LU0122379950.USD","LU0868494617.USD","IE00BBT3K403.USD","LU0289739699.SGD","02228","BK4568","LU0058720904.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","IE00B19Z3581.USD","IE00BLSP4239.USD","BK4550","LU0225284248.USD","LU0225771236.USD","LU0321505439.SGD","LU0306806265.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK1617","LU1883839398.USD","BK4533","BK4599","SG9999011175.SGD","SG9999003800.SGD","BK1141","BK4007","LU0170899867.USD","SG9999002224.SGD","IE0002270589.USD","LU1066053197.SGD","SG9999001176.USD"],"gpt_icon":0},{"id":"2547349860","title":"晶泰科技宣布与辉瑞扩大战略合作共同开发全新一代的分子模拟平台以驱动新药研发。此次合作旨在进一步融合先进的物理算法的精确度","url":"https://stock-news.laohu8.com/highlight/detail?id=2547349860","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547349860?lang=zh_cn&edition=full","pubTime":"2025-06-30 09:54","pubTimestamp":1751248489,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","LU0321505868.SGD","PFE","02228","LU0122379950.USD","BK4592","LU0289739699.SGD","IE00BLSP4239.USD","BK4550","LU0985481810.HKD","LU0058720904.USD","LU0225284248.USD","LU0225771236.USD","BK4534","SGXZ57979304.SGD","BK1617","BK4585","SG9999003800.SGD","LU0868494617.USD","IE00B19Z3581.USD","LU1023059063.AUD","BK4588","LU1057294990.SGD","IE000M9KFDE8.USD","SG9999011175.SGD","SG9999002224.SGD","LU0234572021.USD","LU1894683348.USD","SG9999002232.USD","BK4599","LU1066053197.SGD","SG9999001176.SGD","IE00B19Z3B42.SGD","LU0321505439.SGD","LU1883839398.USD","IE0002270589.USD","LU0170899867.USD","SG9999013999.USD","LU0306807586.USD","SG9999001176.USD","LU1066051498.USD","LU0306806265.USD","BK4533","IE00BLSP4452.SGD","LU0456855351.SGD","BK4581","LU1894683264.USD","BK1141","BK4568","IE00BBT3K403.USD"],"gpt_icon":0},{"id":"2547031978","title":"晶泰科技与辉瑞深化战略合作，共建AI药物与新材料研发分子模拟平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2547031978","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547031978?lang=zh_cn&edition=full","pubTime":"2025-06-30 09:11","pubTimestamp":1751245860,"startTime":"0","endTime":"0","summary":"晶泰科技与辉瑞扩大合作，共建AI驱动的分子模拟平台，提升药物研发效率、精度，覆盖更广化学空间，加速小分子药物发现与开发进程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506300942279530a205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506300942279530a205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1023059063.AUD","BK4007","LU0306807586.USD","LU0321505439.SGD","IE0002270589.USD","LU0289739699.SGD","LU0868494617.USD","IE00BLSP4452.SGD","LU1057294990.SGD","SG9999001176.USD","BK4533","BK4550","LU0985481810.HKD","IE00BBT3K403.USD","SG9999013999.USD","LU0456855351.SGD","LU0058720904.USD","LU0225284248.USD","LU1883839398.USD","LU0321505868.SGD","LU1066051498.USD","PFE","SGXZ57979304.SGD","BK4599","SG9999002224.SGD","LU0234572021.USD","SG9999003800.SGD","SG9999001176.SGD","BK4568","IE000M9KFDE8.USD","LU1066053197.SGD","BK4585","SG9999002232.USD","IE00B19Z3B42.SGD","LU1894683264.USD","IE00BLSP4239.USD","BK4534","LU0306806265.USD","LU0170899867.USD","LU1894683348.USD","LU0225771236.USD","BK4588","LU0122379950.USD","SG9999011175.SGD","BK4592","BK4581","IE00B19Z3581.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pfizer.com","stockEarnings":[{"period":"1week","weight":0.0232},{"period":"1month","weight":0.0972},{"period":"3month","weight":0.1392},{"period":"6month","weight":-0.0462},{"period":"1year","weight":-0.0827},{"period":"ytd","weight":-0.0343}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"辉瑞公司于1942年6月2日根据特拉华州法律成立。公司是一家以研究为基础的全球性生物制药公司。公司运用科学和全球资源，通过发现、开发、制造和分销保健产品（包括创新药物和疫苗），为人们带来延长和显著改善其生活的疗法。公司在发达国家和新兴市场开展工作，致力于促进健康、预防、治疗和治愈这个时代最令人恐惧的疾病。公司与医疗保健提供商、政府和当地社区合作，支持并扩大在全球范围内获得可靠、负担得起的医疗保健服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.001224},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.007083},{"month":3,"riseRate":0.6,"avgChangeRate":0.014714},{"month":4,"riseRate":0.586957,"avgChangeRate":0.018253},{"month":5,"riseRate":0.5,"avgChangeRate":0.007748},{"month":6,"riseRate":0.5,"avgChangeRate":0.002798},{"month":7,"riseRate":0.5,"avgChangeRate":0.013446},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.001198},{"month":9,"riseRate":0.444444,"avgChangeRate":0.003884},{"month":10,"riseRate":0.644444,"avgChangeRate":0.014056},{"month":11,"riseRate":0.688889,"avgChangeRate":0.0279},{"month":12,"riseRate":0.511111,"avgChangeRate":0.009365}],"exchange":"NYSE","name":"辉瑞","nameEN":"Pfizer"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"辉瑞,PFE,辉瑞股票,辉瑞股票老虎,辉瑞股票老虎国际,辉瑞行情,辉瑞股票行情,辉瑞股价,辉瑞股市,辉瑞股票价格,辉瑞股票交易,辉瑞股票购买,辉瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}